MXCT.L - MaxCyte, Inc.
| Previous close | 175.00 |
| Open | 179.90 |
| Bid | 175.00 x 0 |
| Ask | 190.00 x 0 |
| Day's range | 179.90 - 189.25 |
| 52-week range | 95.00 - 189.25 |
| Volume | 13,660 |
| Avg. volume | 38,541 |
| Market cap | 144.937M |
| Beta (5Y monthly) | 1.00 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -25.40 |
| Earnings date | 21 Apr 2020 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 5.03 |
- Stockopedia
Maxcyte Inc hits 52w high – but will it continue?
It's a good time to be a shareholder in Maxcyte Inc (LON:MXCT): as the share approaches its 52-week high, holders may be wondering whether to sell and take the...
- Simply Wall St.
When Can We Expect A Profit From MaxCyte, Inc. (LON:MXCT)?
MaxCyte, Inc.'s (LON:MXCT): MaxCyte, Inc. operates as a cell-based therapies and life sciences company in the United...
- Simply Wall St.
MaxCyte (LON:MXCT) Is In A Good Position To Deliver On Growth Plans
Just because a business does not make any money, does not mean that the stock will go down. For example, although...
- Simply Wall St.
Is MaxCyte, Inc.'s (LON:MXCT) CEO Pay Fair?
In 1999 Doug Doerfler was appointed CEO of MaxCyte, Inc. (LON:MXCT). This analysis aims first to contrast CEO...
- Simply Wall St.
What Kind Of Shareholder Appears On The MaxCyte, Inc.'s (LON:MXCT) Shareholder Register?
If you want to know who really controls MaxCyte, Inc. (LON:MXCT), then you'll have to look at the makeup of its share...
- Simply Wall St.
The MaxCyte (LON:MXCT) Share Price Is Down 49% So Some Shareholders Are Getting Worried
Passive investing in an index fund is a good way to ensure your own returns roughly match the overall market. When you...
- Simply Wall St.
Is MaxCyte, Inc. (LON:MXCT) A Financially Sound Company?
While small-cap stocks, such as MaxCyte, Inc. (LON:MXCT) with its market cap of UK£74m, are popular for their...
